Future Health ESG (NASDAQ:FHLT) announced in an 8-K this morning that it has terminated its combination agreement with medical technology company Excelera Health.
This comes just a few weeks after the SPAC mutually terminated its $100 million PIPE and $20 million forward purchase agreement (“FPA”) with Variant Capital and Hakim. At that time, Future Health had stated that it did not expect the termination of the PIPE and the FPA to impact Excelera’s operations or delay the closing of the deal. The SPAC also noted in early October that it was in discussions with investors to secure alternative strategic financing that would have been less dilutive to its stockholders.
But, it appears these discussions did not materialize into anything further as Future Health sent a termination notice to Excelera on October 31. As a result of the termination, the SPAC is not obligated to pay any penalties pursuant to the terms of the business combination agreement or any related agreements. Future Health and Excelera now mark the 50th deal to be terminated this year.
The parties originally announced the $459 million deal on June 14, 2022. Newport Beach, California-based Excelera operates a just-launched network of physicians serving Medicare patients through a direct contracting entity (DCE) model aimed at reducing costs.
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...